These emerging therapies , Tirzepatide , represent a remarkable advancement in managing metabolic dysfunction and potentially related conditions . They all are classified as GLP-1 receptor activators https://jasonlpej593020.boyblogguide.com/40064333/tirzepatide-a-comprehensive-dive-into-metabolic-agents